
Choisissez votre étiquette
affichée directement sur le flaconBPC-157 Oral
Healing Oral
- Expédié depuis l'Allemagne
Commande
- DHL avec suivi
- Emballage discret
En un coup d'œil
BPC-157 Oral en chiffres
Les chiffres clés de notre lexique.
Article complet du lexique- Class
- Pentadecapeptidehealing, oral
- Use
- Oralcapsule, 500mcg
- Sizes
- 500 mcg1 size in the shop
What studies show
The source in the lexiconStable gastric pentadecapeptide BPC 157 and wound healing (review) (opens in a new tab)
Seiwerth, Sikiric et al., Frontiers in Pharmacology, 2021
Avis
Ce que disent les clients
Uniquement des commandes réelles qui contenaient BPC-157 Oral.
Tous les avisIl n'existe pas encore d'analyse de laboratoire pour BPC-157 Oral. Votez pourFaites-le tester vous-même, nous payons la moitiéToutes les analyses de laboratoire
Connaissances
Tout sur BPC-157 Oral
Informations détaillées bientôt disponibles.
Is the capsule different from the tablet?
Not in terms of the compound. Capsule and tablet both contain BPC-157, only the shell differs. There are no comparative data on capsule versus tablet and no human study of either form.
Is BPC-157 absorbed by mouth at all?
According to a review by the developer group, BPC-157 is stable in human gastric juice. In rat studies it worked via the drinking water much like when injected. There are no blood measurements after oral dosing. After dosing into muscle 14 to 19 percent reached the blood in rats and 45 to 51 percent in dogs, the half-life was under 30 minutes.
What do the animal studies show for the gut?
In rats with a fistula between colon and skin the colon and skin defects healed faster when BPC-157 was injected or added to the drinking water. In short bowel syndrome the animals given BPC-157 by mouth or by injection started gaining weight again right away. There are also findings on alcohol and painkiller damage to the stomach and oesophagus.
Are there studies in humans?
Very few. A systematic review up to June 2026 found three studies with 30 people in total: knee injections, dosing into the bladder and a small safety study into a vein. All without a control group, none with a capsule or tablet. A registered phase 1 tablet trial from 2015 has not published results to this day.
Which trials are running right now?
As of 26 October 2026 no trial with BPC-157 is recruiting. A phase 1 trial with 30 planned participants after shoulder surgery has been announced, where BPC-157 is injected under the skin, with the start planned for January 2027. No capsule trial is registered.
Which side effects are known?
No treatment-related side effects occurred in the three small human studies, but the certainty is very low. One review found no clinical safety data and names risks from unregulated manufacturing and contamination. There are no data of its own on the capsule.
Produits associés
Produits similaires
BPC-157 Oral